FDA to require patients receive risk information
Silver Spring, Maryland—(ENEWSPF)—April 9, 2018
Contact: Deborah Kotz
The U.S. Food and Drug Administration today issued an order to restrict the sale and distribution of the Essure device to ensure that all women considering use of the permanent contraception device are provided with adequate risk information so that they can make informed decisions. The FDA is taking this step…
